Upper Gastrointestinal Endoscopy and Gastrointestinal Biopsy — CPB 0738 | AETNA Coverage Update

Aetna modified CPB 0738 covering upper gastrointestinal endoscopy and GI biopsy, effective October 31, 2025. Here's what billing teams need to act on before that date.

Aetna, a CVS Health company, updated Clinical Policy Bulletin CPB 0738 governing EGD and upper GI endoscopy coverage. This policy covers more than 150 CPT codes — including the full EGD family from 43235 through 43259, esophagoscopy codes 43191 through 43232, and the newer transnasal flexible EGD codes 0652T, 0653T, and 0654T. The coverage policy sets strict medical necessity thresholds, and missing any one criterion is a fast path to claim denial.

Quick-Reference Table

Aetna Upper GI Endoscopy Coverage Criteria and Medical Necessity Requirements 2025

CPB 0738 Aetna system is organized around two distinct tracks: high-risk screening EGDs and diagnostic EGDs. They have different thresholds, and confusing the two is one of the most common reasons these claims get denied.

High-Risk Screening EGD

Aetna covers screening EGD for three specific high-risk populations. First, patients with five or more years of gastroesophageal reflux disease (GERD) who are at risk for Barrett's esophagus. One critical rule here: after a negative screening EGD, Aetna does not consider further screening EGD medically necessary. Document the initial negative result clearly — a repeat screening claim will be denied.

Second, patients with symptomatic pernicious anemia. Aetna requires symptoms to be present — anemia, fatigue, pallor, red tongue, shortness of breath, or tingling and numbness in the hands and feet — to identify prevalent lesions like carcinoid tumors or gastric cancer. Asymptomatic pernicious anemia does not qualify.

Third, patients with cirrhosis and portal hypertension but no prior variceal hemorrhage. Aetna specifically flags patients with platelet counts below 140,000/mm³ or Child's class B or C disease as especially appropriate for this screening.

Diagnostic EGD

The diagnostic EGD track is broader, but each indication still requires specific clinical conditions. Aetna upper GI endoscopy coverage policy requires medical necessity documentation that matches one of the following scenarios — not just a physician's clinical judgment.

The dyspepsia section also adds coverage when any of these are present: chronic GI bleeding, Crohn's disease with persistent dyspepsia, epigastric mass, iron deficiency anemia, persistent vomiting, or progressive difficulty swallowing.

Prior Authorization

Aetna does not make prior authorization requirements explicit within the published CPB 0738 text, but coverage is conditioned entirely on medical necessity criteria being met and documented. For high-volume GI practices, assume that any EGD claim outside the clearest indications — especially repeat procedures or complex interventional EGDs — will face post-payment review. If your practice uses prior auth workflows for Aetna GI procedures, confirm those protocols match the CPB 0738 criteria exactly. If you're unsure, talk to your compliance officer before the October 31, 2025 effective date.

Aetna Upper GI Endoscopy Exclusions and Non-Covered Indications

CPB 0738 is explicit about what does not meet medical necessity. These are common sources of claim denial.

Screening in low-risk populations: Aetna does not cover screening EGD for chronic GERD patients who have already had a negative screening. Once that baseline is established, further screening is not indicated.

Dyspepsia without required trials: Ordering an EGD for dyspepsia before completing the required PPI trial — or before testing for H. pylori and attempting eradication — will result in a non-covered determination.

Asymptomatic pernicious anemia: Patients must have active symptoms. Documentation of labs alone, without clinical symptoms, does not support screening EGD medical necessity under this policy.

Repeat surveillance without documented progression: The policy implies that surveillance intervals and repeat procedures must be tied to documented clinical change or established surveillance protocols. Open-ended repeat EGDs without clear indication will face scrutiny.

Coverage Indications at a Glance

Aetna Upper GI Endoscopy Billing Guidelines and Action Items 2025

Upper GI endoscopy billing is already one of the more complex areas in GI revenue cycle. This CPB 0738 update raises the documentation bar. Here are the actions your team needs to take before October 31, 2025.

CPT, HCPCS, and ICD-10 Codes for Upper GI Endoscopy Under CPB 0738

Covered CPT Codes (When Selection Criteria Are Met)

Note: CPB 0738 includes 150 total CPT codes. The policy data provided above lists 80 codes explicitly. The remaining codes fall within the same EGD and esophagoscopy families. Review the full policy at app.payerpolicy.org/p/aetna/0738 for the complete code list.